Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

3 Cannabis Stocks to Watch in the ‘Green Zone’

By TradeSmith Research Staff
Now could be the time to look at these three cannabis stocks to watch, as each one is currently in the "Green Zone."

Why Is Baudax Bio (BXRX) Stock Up 75% Today?

By Josh Enomoto, InvestorPlace Contributor
Although Baudax Bio saw significant interest because of its orphan drug designation, BXRX stock must climb a wall of worry.

Why Is Synlogic (SYBX) Stock Down 6% Today?

By William White, InvestorPlace Writer
Synlogic stock is sliding lower on Thursday after the biopharmaceutical company announced a reverse split for SYBX shares.

3 Biotech Stocks to Watch Ahead of Potential Obesity Drug Approvals

By Larry Ramer, InvestorPlace Contributor
The demand for obesity drugs is intense and is likely to only greatly increase going forward, since over 40% of Americans were obese in 2020. 

Why Is Bionomics (BNOX) Stock Up 347% Today?

By William White, InvestorPlace Writer
Bionomics stock is rocketing higher as new clinical trial results for its PTSD treatment cause heavy trading of BNOX shares.

7 ‘Strong Buy’ Biotech Stocks to Rejuvenate Your Portfolio

By Josh Enomoto, InvestorPlace Contributor
Dive into these seven strong buy biotech stocks, handpicked by Wall Street, to inject vigor into your investment game.

Jump In Before the Jump Up: 3 Speculative Stocks Ready for a Rally

By Faisal Humayun, InvestorPlace Contributor
These are the speculative stocks to buy for robust returns in the next few months

Don’t Miss the Boom: 3 Psychedelic Stocks Set to Explode Higher

By Matthew Farley, InvestorPlace Contributor
Despite the stigma surrounding psychedelics for personal use, controlled medical experiments indicate their usefulness for treating a variety of conditions.

Don’t Miss the Boom: 3 Pharma Stocks Set to Explode Higher

By Omor Ibne Ehsan
These pharma stocks could boom in the coming years, riding their diversified pipelines with massive addressable markets higher.

From Dust to Diamonds: 7 Undervalued Stocks With Sparkling Prospects

By Yiannis Zourmpanos, InvestorPlace Contributor
Like diamonds in the rough, these undervalued stocks possess the potential to shine brightly in an investment portfolio.

3 Cannabis Stocks That Should Be on Every Investor’s Radar This Fall

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor
The cannabis industry is a quiet place where huge upside potential is building up. As more regions legalize, cannabis stocks can soar.

DNA Stock Alert: Ginkgo Bioworks Announces Major Partnership With Pfizer

By Dana Blankenhorn, InvestorPlace Contributor
The deal keeps Ginkgo alive, but its business model of becoming the "Apple Store of Biotech" remains unproven. DNA stock jumped overnight.

Why Is Know Labs (KNW) Stock Down 37% Today?

By William White, InvestorPlace Writer
Know Labs stock is falling hard on Wednesday as the company priced a public offering for $7 million worth of KNW shares.

Rocket Stocks: 3 Investments Primed to Skyrocket by Year’s End

By Yiannis Zourmpanos, InvestorPlace Contributor
Three companies have thrived thanks to their innovative strategies and adaptability in the face of change.

Cathie Wood’s Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving

By Rich Duprey, InvestorPlace Contributor
Investors tend to closely watch which Cathie Wood stocks are bought and sold as she has history of generating big returns in her ETFs.

Ticking Time Bombs: 3 Biotech Stocks to Dump Before the Damage Is Done

By Chandler Capital, InvestorPlace Contributor
Investors should do their due diligence before investing in these three risky, unreliable and unprofitable biotech stocks.

CR Group Just Sold More Shares of T2 Biosystems (TTOO) Stock

By Josh Enomoto, InvestorPlace Contributor
Despite T2 Biosystems disclosing positive product news, TTOO stock has suffered significant insider selling, posing major risks.

Don’t Miss the Boom: 3 Healthcare Stocks Set to Explode Higher

By Joel Baglole, InvestorPlace Contributor
For these reasons, the healthcare sector is a long-term, growth opportunity for investors. In fact, all segments are forecast to experience growth over the next 15 to 20 years.

Why Is Intercept Pharmaceuticals (ICPT) Stock Up 75% Today?

By Josh Enomoto, InvestorPlace Contributor
Although Intercept Pharmaceuticals popped higher on a buyout deal, many stakeholders of ICPT stock are left wondering what might have been.
Load More Articles